Improving Patient Outcomes with Individualized
Therapy in the Management of HIV/AIDS

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session at the 2016 Fall Forum. If you participated in
the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 31, 2017 to January 31, 2018

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.  To print or save your certificate, you will need to click on the “download” button and either print or save.

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This educational activity is supported by an educational grant from
ViiV Healthcare

The human immunodeficiency virus (HIV) is a lentivirus that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Fortunately for patients with HIV, several new therapies have recently become available for clinicians. Antiretroviral therapy (ART) has evolved considerably over the past three decades with many antiretroviral (ARV) drugs, combinations, and classes available. Cobicistat-boosted protease inhibitors (PI) are also evolving and one of the biggest challenges for clinicians is individualizing care and understanding when certain ARV therapies and strategies are appropriate, and when they are not. Numerous studies have shown that ARV therapy must be tailored to the individual patient and his or her abilities and diverse needs. Options for HIV prevention and treatment continue to expand at a rapid pace.

Upon Completion of this activity, participants will be able to:

  • Examine recent clinical data on the safety and efficacy of new HIV therapies to individualize care and improve patient outcomes

  • Individualize antiretroviral therapy regimens based on the patient's clinical and laboratory

  • characteristics, history, and health status, as well as the presence of any co-occurring or comorbid conditions

  • Analyze guidelines and evidence on the initial treatment and treatment switching to the development of HIV benefit design and patient access plans

  • Apply methods to enable optimal cost management of antiretroviral therapy to be realized by multiple HIV stakeholders

  • Identify therapeutic regimens that improve patient adherence to treatment and that are less likely to induce viral resistance

  • Describe current and evolving strategies used by managed care organizations (MCOs) to facilitate high quality care for members with HIV

Faculty: Ian Frank, MD
Associate Professor of Medicine
University of Pennsylvania


Dr. Frank serves on an advisory board/panel for Gilead Sciences and receives research support from GlaxoSmithKline and ViiV. He does plan on discussing off label use of cabotegravir and injectable rilpivirine. His presentation has been peer reviewed.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jacquelyn Smith, RN, BSN, MA, CMCN has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.
Will Williams has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

The National Association of Managed Care Physicians designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity and turn in a validation form will receive up to 1 credit in continuing nursing education.

The American Board of Managed Care Nurses has approved this activity for a maximum of 1 contact hour towards CMCN recertification.

This educational activity is supported by an educational grant from
ViiV Healthcare

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue